Lv31
316 积分 2024-03-29 加入
Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study
5小时前
待确认
Review and prospect of CD146 research
2个月前
已完结
EV280/#983 Impact of first-line bevacizumab on survival outcomes in advanced ovarian clear cell carcinoma
3个月前
已关闭
The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis
5个月前
已完结
Symptom Control in Patients With Recurrent Ovarian Cancer: Measuring the Benefit of Palliative Chemotherapy in Women With Platinum Refractory/Resistant Ovarian Cancer
5个月前
已完结
521MO Efficacy of pembrolizumab monotherapy (PM) for advanced clear cell gynaecological cancer (CCGC): Phase II PEACOCC trial
5个月前
已完结
Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100
5个月前
已完结
ARE CLEAR CELL CARCINOMA AND MUCINOUS CARCINOMA OF THE OVARY SENSITIVE TO COMBINATIN CHEMOTHERAPY WITH PACLITAXEL AND CARBOPLATIN?: A MULTI-INSTITUTE PROSPECTIVE STUDY(GOGO-OV1)
6个月前
已关闭
Phase II trial of pembrolizumab and epacadostat in recurrent clear cell carcinoma of the ovary: An NRG oncology study GY016
6个月前
已完结
Crocus sativus tepals extract suppresses subcutaneous adipose tissue hypertrophy and improves systemic insulin sensitivity in mice on high‐fat diet
10个月前
已采纳
Recalcitrant dermatophyte infections: identification and risk factors
10个月前
已采纳
Pubertal development and premature ovarian insufficiency in patients with APECED
10个月前
已采纳
What Are We Missing? Magnetic Resonance Imaging-negative Clinically Significant Prostate Cancer in PROMIS
10个月前
已采纳
A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)
10个月前
已采纳
Re: Konrad H. Stopsack. Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024
10个月前
已采纳
皖公网安备34019202002308
